14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today APRI ranks #16542 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Apricus Biosciences Stock Forecast NASDAQ:APRI

$1.64 (-5.75%)

Volume: 5M

Closed: Dec 03, 2021

Hollow Logo Score: -5.770

Apricus Biosciences Stock Forecast

$1.64 (-5.75%)

Volume: 5M

Closed: Dec 03, 2021

Score Hollow Logo -5.770
Which way will APRI go? Request

APRI Stock Risk

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.17 between high and low, or 10.69%. For the last week, the stock has had a daily average volatility of 9.62%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 26 and the stock is currently not being overbought or oversold

Big movements in Apricus Biosciences stock price on Friday moving 10.69% between high and low
(Updated on Dec 03, 2021)


Sell candidate since 2021-11-16 Loss -23.00%

The Apricus Biosciences stock price fell by -5.75% on the last day (Friday, 3rd Dec 2021) from $1.74 to $1.64. During the day the stock fluctuated 10.69% from a day low at $1.59 to a day high of $1.76. The price has fallen in 8 of the last 10 days and is down by -15.46% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 million shares were bought and sold for approximately $8.83 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.61 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.78% during the next 3 months and, with a 90% probability hold a price between $1.45 and $2.15 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, December 01, 2021, and so far it has risen 1.23%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Apricus Biosciences stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.74 and $2.08. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Apricus Biosciences finds support from accumulated volume at $1.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.17 between high and low, or 10.69%. For the last week, the stock has had a daily average volatility of 9.62%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Apricus Biosciences stock A Buy?

Apricus Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.770

Predicted Opening Price for Apricus Biosciences of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$1.66 $1.64 (Undervalued)
Strong Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 9.62 %
Overall Risk: Very High High Medium Low Very Low
Volatility
9.62 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $1.74
Price: $1.64
Support: $1.62

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.83 11.79 %
1.77 7.83 %
1.73 5.38 %
Current price: 1.64
Support 1.60 -2.54 %
1.56 -4.98 %
1.49 -8.94 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 1.94 18.29 %
1.88 14.63 %
1.74 6.10 %
Current price 1.64
Support 1.62 -1.22%
0 .
0 .

Click to get the best stock tips daily for free!

About Apricus Biosciences

Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company’s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals Int... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT